An in-vitro immunological assay for diagnosis of coeliac disease.
Production of leucocyte-migration-inhibition factor (L.I.F.) by peripheral-blood lymphocytes in response to challenge with gluten fractions was studied in 55 patients with coeliac disease and in 32 controls. 96% of the patients with coeliac disease demonstrated significant L.I.F. reaction in response to gluten fractions irrespective of their dietary status. Only 2 out of 32 controls had a positive reaction. This was in response to the B2 or B3 fraction, but never to both. The agarose microdroplet method of L.I.F. assay is reliable and technically simple enough for use in most clinical laboratories. The assay of L.I.F. production by peripheral-blood lymphocytes in response to gluten fractions, would be a useful adjunct in the diagnosis of gluten-sensitive enteropathy.
D000293:Adolescent; D000485:Allergens; D002446:Celiac Disease / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D002464:Cell Migration Inhibition / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005983:Glutens / Q000276:immunology / Q000633:toxicity; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D037102:Lectins / Q000494:pharmacology; D007962:Leukocytes / Q000276:immunology; D008263:Macrophage Migration-Inhibitory Factors / Q000096:biosynthesis; D008297:Male; D012685:Sepharose
D000485:Allergens; D037102:Lectins; D008263:Macrophage Migration-Inhibitory Factors; D005983:Glutens; D012685:Sepharose